Preclinical evaluation of injectable bone substitute materials

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 3, 2015, Pages 191-209

  Bongio, Matilde ^a   van den Beucken, Jeroen J J P ^a   Leeuwenburgh, Sander C G ^a   Jansen, John A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal models; Bone augmentation; Bone defect; Bone substitutes; Ceramic based biomaterials; Hydrogel based biomaterials; Injectable; Preclinical studies

Indexed keywords

ANIMALS; BONE; CERAMIC MATERIALS; CLINICAL RESEARCH; DEFECTS;

ANIMAL MODEL; BONE AUGMENTATION; BONE DEFECT; BONE SUBSTITUTE MATERIALS; BONE SUBSTITUTES; CERAMIC-BASED BIOMATERIAL; HYDROGEL-BASED BIOMATERIAL; INJECTABLES; PRECLINICAL STUDIES; READY TO USE;

BIOMATERIALS;

BIOMATERIAL; BONE PROSTHESIS;

ALVEOLAR BONE; BIOCOMPATIBILITY; BIODEGRADABILITY; BONE DEFECT; BONE PROSTHESIS; BONE REGENERATION; BONE TISSUE; CALVARIA; CLINICAL EVALUATION; DISTRACTION OSTEOGENESIS; EPIPHYSIS; FENESTRATION; FRACTURE HEALING; HUMAN; INJECTABLE BONE SUBSTITUTE; MAXILLARY SINUS; METAPHYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOOTH EXTRACTION; TOOTH SOCKET; VERTEBRA MALFORMATION; VISCOSITY; ADVERSE EFFECTS; ANIMAL; BONE DISEASES; DISEASE MODEL; DRUG SCREENING; PHARMACOLOGY; PROCEDURES; STANDARDS;

ANIMALS; BONE DISEASES; BONE SUBSTITUTES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS;

EID: 84925603861     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1637     Document Type: Review

References (186)

1. Acarturk O, Lehmicke M, Aberman H, et al. 2008; Bone healing response to an injectable calcium phosphate cement with enhanced radio-opacity. J Biomed Mater Res B Appl Biomater 86B: 56-62.
2. Adhikari R, Gunatillake PA, Griffiths I, et al. 2008; Biodegradable injectable polyurethanes: synthesis and evaluation for orthopaedic applications. Biomaterials 29: 3762-3770.
3. Aerssens J, Boonen S, Lowet G, et al. 1998; Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology 139: 663-670.
4. Aho AJ, Tirri T, Kukkonen J, et al. 2004; Injectable bioactive glass/biodegradable polymer composite for bone and cartilage reconstruction: concept and experimental outcome with thermoplastic composites of poly(ε{lunate}-caprolactone-co- d, l-lactide) and bioactive glass S53P4. J Mater Sci Mater Med 15: 1165-1173.
5. Akahane M, Shigematsu H, Tadokoro M, et al. 2010; Scaffold-free cell sheet injection results in bone formation. J Tissue Eng Regen Med 4: 404-411.
6. Amini AA, Nair LS. 2012; Injectable hydrogels for bone and cartilage repair. Biomed Mater 7: 024105.
7. Anseth KS, Shastri VR, Langer R. 1999; Photopolymerizable degradable polyanhydrides with osteocompatibility. Nat Biotechnol 17: 156-159.
8. Apelt D, Theiss F, El-Warrak AO, et al. 2004; In vivo behavior of three different injectable hydraulic calcium phosphate cements. Biomaterials 25: 1439-1451.
9. Aral A, Yalcin S, Karabuda ZC, et al. 2008; Injectable calcium phosphate cement as a graft material for maxillary sinus augmentation: an experimental pilot study. Clin Oral Implants Res 19: 612-617.
10. Araujo MG, Liljenberg B, Lindhe J. 2010; Dynamics of Bio-Oss® collagen incorporation in fresh extraction wounds: an experimental study in the dog. Clin Oral Implants Res 21: 55-64.
11. Araujo MVF, Mendes VC, Chattopadhyay P, et al. 2010; Low-temperature particulate calcium phosphates for bone regeneration. Clin Oral Implants Res 21: 632-641.
12. Arisan V, Anil A, Wolke JGC, et al. 2010; The effect of injectable calcium phosphate cement on bone anchorage of titanium implants: an experimental feasibility study in dogs. Int J Oral Maxillofac Surg 39: 463-468.
13. Arisan V, Ozdemir T, Anil A, et al. 2008; Injectable calcium phosphate cement as a bone-graft material around peri-implant dehiscence defects: a dog study. Int J Oral Maxillofac Implants 23: 1053-1062.
14. Auer JA, Goodship A, Arnoczky S, et al. 2007; Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use. BMC Musculoskeletal Disord 8: 72.
15. Bai B, Yin ZX, Xu Q, et al. 2009; Histological changes of an injectable rhBMP-2/calcium phosphate cement in vertebroplasty of rhesus monkey. Spine 34: 1887-1892.
16. Baroth S, Bourges X, Goyenvalle E, et al. 2009; Injectable biphasic calcium phosphate bioceramic: the HYDROS® concept. Biomed Mater Eng 19: 71-76.
17. Blattert TR, Delling G, Dalal PS, et al. 2002; Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine. Spine 27: 2697-2705.
18. Blattert TR, Delling G, Weckbach A. 2003; Evaluation of an injectable calcium phosphate cement as an autograft substitute for transpedicular lumbar interbody fusion: a controlled, prospective study in the sheep model. Eur Spine J 12: 216-223.
19. Blouin S, Moreau MF, Weiss P, et al. 2006; Evaluation of an injectable bone substitute (β-TCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats. J Biomed Mat Res A 78A: 570-580.
20. Bohner M. 2010; Design of ceramic-based cements and putties for bone graft substitution. Eur Cell Mater 20: 1-12.
21. Bohner M, Baroud G. 2005; Injectability of calcium phosphate pastes. Biomaterials 26: 1553-1563.
22. Bohner M, Gbureck U, Barralet JE. 2005; Technological issues for the development of more efficient calcium phosphate bone cements: a critical assessment. Biomaterials 26: 6423-6429.
23. Boix D, Gauthier O, Guicheux J, et al. 2004; Alveolar bone regeneration for immediate implant placement using an injectable bone substitute: an experimental study in dogs. J Periodontol 75: 663-671.
24. Boix D, Weiss P, Gauthier O, et al. 2006; Injectable bone substitute to preserve alveolar ridge resorption after tooth extraction: a study in dog. J Mater Sci Matern Med 17: 1145-1152.
25. Bongio M, van den Beucken JJJP, Leeuwenburgh SCG, et al. 2010; Development of bone substitute materials: from 'biocompatible' to 'instructive'. J Mat Chem 20: 8747-8759.
26. Burdick JA. 2012; Injectable gels for tissue/organ repair. Biomed Mater 7(2): 020201.
27. Burg KJL, Porter S, Kellam JF. 2000; Biomaterial developments for bone tissue engineering. Biomaterials 21: 2347-2359.
28. Busenlechner D, Tangl S, Fitzl C, et al. 2009; Paste-like inorganic bone matrix: preclinical testing of a prototype preparation in the porcine calvaria. Clin Oral Implants Res 20: 1099-1104.
29. Cardaropoli G, Araujo M, Hayacibara R, et al. 2005; Healing of extraction sockets and surgically produced - augmented and non-augmented - defects in the alveolar ridge. An experimental study in the dog. J Clin Periodontol 32: 435-440.
30. Cho BC, Chung HY, Lee DG, et al. 2005; The effect of chitosan bead encapsulating calcium sulfate as an injectable bone substitute on consolidation in the mandibular distraction osteogenesis of a dog model. J Oral Maxillofac Surg 63: 1753-1764.
31. Chow PKH. 2008; The rationale for the use of animal models in biomedical research. In Using Animal Models in Biomedical Research - A Primer for the Investigator. World Scientific Publishing Co. Pte. Ltd.: Singapore.
32. Claes L, Maurer-Klein N, Henke T, et al. 2006; Moderate soft tissue trauma delays new bone formation only in the early phase of fracture healing. J Orthop Res 24: 1178-1185.
33. Comuzzi L, Ooms E, Jansen JA. 2002; Injectable calcium phosphate cement as a filler for bone defects around oral implants: an experimental study in goats. Clin Oral Implants Res 13: 304-311.
34. Corchon MAG, Salvado M, de la Torre BJ, et al. 2006; Injectable and self-curing composites of acrylic/bioactive glass and drug systems. A histomorphometric analysis of the behaviour in rabbits. Biomaterials 27: 1778-1787.
35. Cuisinier FJ, Wieber A, Tenenbaum H, et al. 2003; Injectable calcium phosphate hydraulic cement (CPHC) used for periodontal tissue regeneration: a study of a dog model. J Appl Biomater Biomech 1: 186-195.
36. Daculsi G, Uzel AP, Weiss P, et al. 2010; Developments in injectable multiphasic biomaterials. The performance of microporous biphasic calcium phosphate granules and hydrogels. J Mater Sci Mater Med 21: 855-861.
37. del Valle S, Mino N, Munoz F, et al. 2007; In vivo evaluation of an injectable macroporous calcium phosphate cement. J Mater Sci Mater Med 18: 353-361.
38. Docherty-Skogh AC, Bergman K, Waern MJ, et al. 2010; Bone morphogenetic protein-2 delivered by hyaluronan-based hydrogel induces massive bone formation and healing of cranial defects in minipigs. Plast Reconstr Surg 125: 1383-1392.
39. Drury JL, Mooney DJ. 2003; Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24: 4337-4351.
40. Dumas JE, Zienkiewicz K, Tanner SA, et al. 2010; Synthesis and characterization of an injectable allograft bone/polymer composite bone void filler with tunable mechanical properties. Tissue Eng Part A 16: 2505-2518.
41. Dupras TL, Schultz JJ, Wheeler SM, et al. 2011; Human skeletal terminology. In Forensic Recovery of Human Remains: Archaeological Approaches, 2nd edn. CRC Press: Florida, United States.
42. Edwards RB, Seeherman HJ, Bogdanske JJ, et al. 2004; Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J Bone Joint Surg Am 86A: 1425-1438.
43. Einhorn TA. 1999; Clinically applied models of bone regeneration in tissue engineering research. Clin Orthop Relat Res 367(suppl): S59-67.
44. Eitel F, Klapp F, Jacobson W, et al. 1981; Bone regeneration in animals and in man. A contribution to understanding the relative value of animal experiments to human pathophysiology. Arch Orthop Trauma Surg 99: 59-64.
45. Fellah BH, Weiss P, Gauthier O, et al. 2006; Bone repair using a new injectable self-crosslinkable bone substitute. J Orthop Res 24: 628-635.
46. Fini M, Motta A, Torricelli P, et al. 2005; The healing of confined critical size cancellous defects in the presence of silk fibroin hydrogel. Biomaterials 26: 3527-3536.
47. Flautre B, Delecourt C, Blary MC, et al. 1999; Volume effect on biological properties of a calcium phosphate hydraulic cement: experimental study in sheep. Bone 25: 35-39S.
48. Flautre B, Maynou C, Lemaitre J, et al. 2002; Bone colonization of β-TCP granules incorporated in brushite cements. J Biomed Mater Res 63: 413-417.
49. Frankenburg EP, Goldstein SA, Bauer TW, et al. 1998; Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg Am 80A: 1112-1124.
50. Fuegl A, Tangl S, Keibl C, et al. 2011; The impact of ovariectomy and hyperglycemia on graft consolidation in rat calvaria. Clin Oral Implants Res 22: 524-529.
51. Gauthier C. 2007; The institutional animal care committee: keystone of international harmonization. In AATEX 14. Proceedings of the 6th World Congress on Alternatives and Animal Use in the Life Sciences. Special Issue: 157-161.
52. Gauthier O, Boix D, Grimandi G, et al. 1999; A new injectable calcium phosphate biomaterial for immediate bone filling of extraction sockets: a preliminary study in dogs. J Periodontol 70: 375-383.
53. Gauthier O, Bouler JM, Aguado E, et al. 1998; Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials 19: 133-139.
54. Gauthier O, Bouler JM, Weiss P, et al. 1999; Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution. Bone 25: 71-74S.
55. Gauthier O, Bouler JM, Weiss P, et al. 1999; Kinetic study of bone ingrowth and ceramic resorption associated with the implantation of different injectable calcium phosphate bone substitutes. J Biomed Mater Res 47: 28-35.
56. Gauthier O, Khairoun I, Bosco J, et al. 2003; Noninvasive bone replacement with a new injectable calcium phosphate biomaterial. J Biomed Mater Res A 66A: 47-54.
57. Gauthier O, Muller R, von Stechow D, et al. 2005; In vivo bone regeneration with injectable calcium phosphate biomaterial: a three-dimensional micro-computed tomographic, biomechanical and SEM study. Biomaterials 26: 5444-5453.
58. Gu Y, Chen LA, Yang HL, et al. 2011; Evaluation of an injectable silk fibroin enhanced calcium phosphate cement loaded with human recombinant bone morphogenetic protein-2 in ovine lumbar interbody fusion. J Biomed Mater Res A 97A: 177-185.
59. Habraken WJEM, de Jonge LT, Wolke JGC, et al. 2008; Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A 87A: 643-655.
60. Habraken WJEM, Wolke JGC, Mikos AG, et al. 2006; Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed 17: 1057-1074.
61. Hannink G, Wolke JGC, Schreurs BW, et al. 2008; In vivo behavior of a novel injectable calcium phosphate cement compared with two other commercially available calcium phosphate cements. J Biomed Mater Res B Appl Biomater 85B: 478-488.
62. Hayashi C, Kinoshita A, Oda S, et al. 2006; Injectable calcium phosphate bone cement provides favorable space and a scaffold for periodontal regeneration in dogs. J Periodontol 77: 940-946.
63. He YQ, Gao JP, Li XL, et al. 2010; Fabrication of injectable calcium sulfate bone graft material. J Biomater Sci Polym Ed 21: 1313-1330.
64. Hennink WE, van Nostrum CF. 2002; Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev 54: 13-36.
65. Hile DD, Kowaleski MP, Doherty SA, et al. 2005; An injectable porous poly(propylene glycol-co-fumaric acid) bone repair material as an adjunct for intramedullary fixation. Biomed Mater Eng 15: 219-227.
66. Hing KA. 2004; Bone repair in the twenty-first century: biology, chemistry or engineering? Phil Trans R Soc Lond A (Math, Phys Eng Sci) 362: 2821-2850.
67. Ho E, Lowman A, Marcolongo M. 2006; Synthesis and characterization of an injectable hydrogel with tunable mechanical properties for soft tissue repair. Biomacromolecules 7: 3223-3228.
68. Hoekstra JWM, Meijer GJ, van den Beucken JJJP, et al. 2012; Maxillary sinus floor augmentation with injectable calcium phosphate cements: a pre-clinical study in sheep. Clin Oral Implants Res DOI: 10.1111/j.1600-0501.2012.0242.
69. Hoekstra JWM, van den Beucken JJJP, Leeuwenburgh SCG, et al. 2011; Tantalumpentoxide as a radiopacifier in injectable calcium phosphate cements for bone substitution. Tissue Eng Part C Methods 17: 907-913.
70. Horner EA, Kirkham J, Wood D, et al. 2010; Long bone defect models for tissue engineering applications: criteria for choice. Tissue Eng Part B Rev 16: 263-271.
71. Indovina A, Block MS. 2002; Comparison of three bone substitutes in canine extraction sites. J Oral Maxillofac Surg 60: 53-58.
72. Ito K, Yamada Y, Nagasaka T, et al. 2005; Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-oss®), platelet-rich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res A 73A: 63-72.
73. Kawagoe K, Saito M, Shibuya T, et al. 2000; Augmentation of cancellous screw fixation with hydroxyapatite composite resin (CAP) in vivo. J Biomed Mater Res 53: 678-684.
74. Khairoun I, Magne D, Gauthier O, et al. 2002; In vitro characterization and in vivo properties of a carbonated apatite bone cement. J Biomed Mater Res 60: 633-642.
75. Kirschner RE, Karmacharya J, Ong G, et al. 2002; Repair of the immature craniofacial skeleton with a calcium phosphate cement: quantitative assessment of craniofacial growth. Ann Plast Surg 49: 33-38.
76. Klijn RJ, Hoekstra JWM, van den Beucken JJJP, et al. 2012; Maxillary sinus augmentation with microstructured tricalcium phosphate ceramic in sheep. Clin Oral Implants Res 23: 274-280.
77. Klijn RJ, van den Beucken JJJP, Félix Lanao RP, et al. 2012b; Three different strategies to obtain porous calcium phosphate cements: comparison of performance in a rat skull bone augmentation model. Tissue Eng Part A 18(11-12): 1171-1182.
78. Knaack D, Goad MEP, Aiolova M, et al. 1998; Resorbable calcium phosphate bone substitute. J Biomed Mater Res 43: 399-409.
79. Kneser U, Schaefer DJ, Polykandriotis E, et al. 2006; Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10: 7-19.
80. Kobayashi H, Fujishiro T, Belkoff SM, et al. 2009; Long-term evaluation of a calcium phosphate bone cement with carboxymethyl cellulose in a vertebral defect model. J Biomed Mater Res A 88A: 880-888.
81. Kobayashi N, Ong K, Villarraga M, et al. 2007; Histological and mechanical evaluation of self-setting calcium phosphate cements in a sheep vertebral bone void model. J Biomed Mater Res A 81A: 838-846.
82. Kochi G, Sato S, Ebihara H, et al. 2010; A comparative study of microfocus CT and histomorphometry in the evaluation of bone augmentation in rat calvarium. J Oral Sci 52: 203-211.
83. Kopylov P, Tagil M, Aspenberg P. 2001; Delayed surgery does not reduce the interface strength between the surface of a bone fracture and a self-curing injectable hydroxyapatite (Norian SRS). Scand J Plast Reconstr Surg Hand Surg 35: 129-133.
84. Krebs HA, Krebs JR. 1980; The August Krogh principle. Comp Biochem Physiol B Biochem Mol Biol 67: 379-380.
85. Krogh A. 1929; Progress of physiology. Am J Physiol 90: 243-221.
86. Kwon DH, Bennett W, Herberg S, et al. 2010; Evaluation of an injectable rhGDF-5/PLGA construct for minimally invasive periodontal regenerative procedures: a histological study in the dog. J Clin Periodontol 37: 390-397.
87. Kwon DH, Bisch FC, Herold RW, et al. 2010; Periodontal wound healing/regeneration following the application of rhGDF-5 in a β-TCP/PLGA carrier in critical-size supra-alveolar periodontal defects in dogs. J Clin Periodontol 37: 667-674.
88. Kwon HR, Wikesjo UME, Park JC, et al. 2010c; Growth/differentiation factor-5 significantly enhances periodontal wound healing/regeneration compared with platelet-derived growth factor-BB in dogs. J Clin Periodontol 37: 739-746.
89. Lamghari M, Berland S, Laurent A, et al. 2001; Bone reactions to nacre injected percutaneously into the vertebrae of sheep. Biomaterials 22: 555-562.
90. Lamghari M, Huet H, Laurent A, et al. 1999; A model for evaluating injectable bone replacements in the vertebrae of sheep: radiological and histological study. Biomaterials 20: 2107-2114.
91. Lanao RPF, Leeuwenburgh SCG, Wolke JGC, et al. 2011; Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles. Biomaterials 32: 8839-8847.
92. Larsson S, Hannink G. 2011; Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments. Injury 42: S30-34.
93. Le Guehennec L, Goyenvalle E, Aguado E, et al. 2005; MBCP® biphasic calcium phosphate granules and Tissucol® sealant in rabbit femoral defects: the effect of fibrin on bone ingrowth. J Mater Sci Mater Med 16: 29-35.
94. Lee JS, Wikesjo UME, Jung UW, et al. 2010; Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 in a β-tricalcium phosphate carrier into one-wall intrabony defects in dogs. J Clin Periodontol 37: 382-389.
95. Lee TJ, Kang SW, Bhang SH, et al. 2010; Apatite-coated porous poly(lactic-co-glycolic acid) microspheres as an injectable bone substitute. J Biomater Sci Polym Ed 21: 635-645.
96. Lerouxel E, Weiss P, Giumelli B, et al. 2006; Injectable calcium phosphate scaffold and bone marrow graft for bone reconstruction in irradiated areas: an experimental study in rats. Biomaterials 27: 4566-4572.
97. Leung KS, Siu WS, Li SF, et al. 2006; An in vitro optimized injectable calcium phosphate cement for augmenting screw fixation in osteopenic goats. J Biomed Mater Res B Appl Biomater 78B: 153-160.
98. Li M, Liu XY, Liu XD, et al. 2010; Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: a pilot study. Clin Orthop Relat Res 468: 1978-1985.
99. Li RH, Bouxsein ML, Blake CA, et al. 2003; rhBMP-2 injected in a calcium phosphate paste (α-BSM) accelerates healing in the rabbit ulnar osteotomy model. J Orthop Res 21: 997-1004.
100. Liao H, Walboomers XF, Habraken WJ, et al. 2011; Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect. Acta Biomater 7: 1752-1759.
101. Liebschner MAK. 2004; Biomechanical considerations of animal models used in tissue engineering of bone. Biomaterials 25: 1697-1714.
102. Link D, van den Dolder J, van den Beucken JJJP, et al. 2008; Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-β1 loaded gelatin microparticles. Biomaterials 29: 675-682.
103. Lippens E, Vertenten G, Girones J, et al. 2010; Evaluation of bone regeneration with an injectable, in situ polymerizable Pluronic® F127 hydrogel derivative combined with autologous mesenchymal stem cells in a goat tibia defect model. Tissue Eng Part A 16: 617-627.
104. Liu YC, Ahmad S, Shu XZ, et al. 2006a; Accelerated repair of cortical bone defects using a synthetic extracellular matrix to deliver human demineralized bone matrix. J Orthop Res 24: 1454-1462.
105. Liu YC, Shu XZ, Prestwich GD. 2006b; Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng 12: 3405-3416.
106. Lopez-Heredia M, Bongio M, Cunha AM, et al. 2012; Bone formation analysis: effect of quantification procedures on the study outcome. Tissue Eng Part C Methods 18: 369-373.
107. Low KL, Tan SH, Zein SHS, et al. 2010; Calcium phosphate-based composites as injectable bone substitute materials. J Biomed Mater Res B Appl Biomater 94B: 273-286.
108. Luca L, Rougemont AL, Walpoth BH, et al. 2010; The effect of carrier nature and pH on rhBMP-2-induced ectopic bone formation. J Control Release 147: 38-44.
109. Luca L, Rougemont AL, Walpoth BH, et al. 2011; Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect. J Biomed Mat Res A 96A: 66-74.
110. Mano JF, Sousa RA, Boesel LF, et al. 2004; Bioinert, biodegradable and injectable polymeric matrix composites for hard tissue replacement: state of the art and recent developments. Comp Sci Technol 64: 789-817.
111. Martinez-Sanz E, Ossipov DA, Hilborn J, et al. 2011; Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. J Control Release 152: 232-240.
112. Maus U, Andereya S, Gravius S, et al. 2008a; BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep. J Biomater Appl 22: 559-576.
113. Maus U, Andereya S, Gravius S, et al. 2008b; Lack of effect on bone healing of injectable BMP-2 augmented hyaluronic acid. Arch Orthop Trauma Surg 128: 1461-1466.
114. Medical Research Modernization Committee: http://www.mrmcmed.org/
115. Morris MS, Lee Y, Lavin MT, et al. 2008; Injectable simvastatin in periodontal defects and alveolar ridges: pilot studies. J Periodontol 79: 1465-1473.
116. Nanci A, Bosshardt DD. 2006; Structure of periodontal tissues in health and disease. Periodontol 2000 40: 11-28.
117. Neyt JG, Buckwalter JA, Carroll NC. 1998; Use of animal models in musculoskeletal research. Iowa Orthop J 18: 118-123.
118. Nuffield Council on Bioethics. 2005; The ethics of research involving animals. Nuffield Council on Bioethics.
119. Ooms EM, Wolke JGC, van der Waerden JPCM, et al. 2002; Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J Biomed Mater Res 61: 9-18.
120. Ooms EM, Wolke JGC, van der Waerden JPCM, et al. 2003; Use of injectable calcium-phosphate cement for the fixation of titanium implants: an experimental study in goats. J Biomed Mater Res B Appl Biomater 66B: 447-456.
121. Ornoy A. 1995; Animal models of human related calcium metabolic disorders. In Animal Models. CRC Press: Boca Raton, FL.
122. Pasquier G, Flautre B, Blary MC, et al. 1996; Injectable percutaneous bone biomaterials: an experimental study in a rabbit model. J Mater Sci Mater Med 7: 683-690.
123. Pearce AI, Richards RG, Milz S, et al. 2007; Animal models for implant biomaterial research in bone: a review. Eur Cell Mater 13: 1-10.
124. Peterson B, Whang PG, Iglesias R, et al. 2004; Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am 86A: 2243-2250.
125. Phillips FM, Turner AS, Seim HB, et al. 2006; In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine 6: 500-506.
126. Plachokova A, Link D, van den Dolder J, et al. 2007a; Bone regenerative properties of injectable PGLA-CaP composite with TGF-β1 in a rat augmentation model. J Tissue Eng Regen Med 1: 457-464.
127. Plachokova AS, van den Dolder J, Stoelinga PJ, et al. 2007b; Early effect of platelet-rich plasma on bone healing in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res 18: 244-251.
128. Premarked notification (510K), FDA: http://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/premarketsubmissions/premarketnotification510k/default.htm
129. Qi XP, Ye JD, Wang YJ. 2008; Improved injectability and in vitro degradation of a calcium phosphate cement containing poly(lactide-co-glycolide) microspheres. Acta Biomater 4: 1837-1845.
130. Raines AL, Sunwoo M, Gertzman AA, et al. 2011; Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation. J Biomed Mater Res A 96A: 575-583.
131. Reinwald S, Burr D. 2008; Review of nonprimate, large animal models for osteoporosis research. J Bone Miner Res 23: 1353-1368.
132. Rimondini L, Nicoli-Aldini N, Fini M, et al. 2005; In vivo experimental study on bone regeneration in critical bone defects using an injectable biodegradable PLA/PGA copolymer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99: 148-154.
133. Rosen PS, Reynolds MA, Bowers GM. 2000; The treatment of intrabony defects with bone grafts. Periodontol 2000 22: 88-103.
134. Ruhe PQ, Hedberg-Dirk EL, Padron NT, et al. 2006; Porous poly( dl-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 12: 789-800.
135. Russell WMS, Burch RL. 1959; The Principles of Humane Experimental Technique. Universities Federation for Animal Welfare: Potters Bar, Herts, UK.
136. Sanzana ES, Navarro M, Macule F, et al. 2008; Of the in vivo behavior of calcium phosphate cements and glasses as bone substitutes. Acta Biomater 4: 1924-1933.
137. Sasaki N, Minami T, Yamada K, et al. 2008; In vivo effects of intra-articular injection of gelatin hydrogen microspheres containing basic fibroblast growth factor on experimentally induced defects in third metacarpal bones of horses. Am J Vet Res 69: 1555-1559.
138. Sato I, Akizuki T, Oda S, et al. 2009; Histological evaluation of alveolar ridge augmentation using injectable calcium phosphate bone cement in dogs. J Oral Rehabil 36: 762-769.
139. Schwartz Z, Doukarsky-Marx T, Nasatzky E, et al. 2008; Differential effects of bone graft substitutes on regeneration of bone marrow. Clin Oral Implants Res 19: 1233-1245.
140. Seeherman HJ, Azari K, Bidic S, et al. 2006; rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am 88A: 1553-1565.
141. Seeherman HJ, Bouxsein M, Kim H, et al. 2004; Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a non-human primate model. J Bone Joint Surg Am 86A: 1961-1972.
142. Sheyn D, Kallai I, Tawackoli W, et al. 2011; Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol Pharm 8: 1592-1601.
143. Shirakata Y, Oda S, Kinoshita A, et al. 2002; Histocompatible healing of periodontal defects after application of an injectable calcium phosphate bone cement. A preliminary study in dogs. J Periodontol 73: 1043-1053.
144. Shirakata Y, Taniyama Y, Yoshimoto T, et al. 2011; Effect of bone swaging with calcium phosphate bone cement on periodontal regeneration in dogs. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 114(1): 35-42.
145. Shirakata Y, Yoshimoto T, Goto H, et al. 2007; Favorable periodontal healing of 1-wall infrabony defects after application of calcium phosphate cement wall alone or in combination with enamel matrix derivative: a pilot study with canine mandibles. J Periodontol 78: 889-898.
146. Solchaga LA, Hee CK, Aguiar DJ, et al. 2011; Augment® bone graft products compare favorably to autologous bone graft in an ovine model of lumbar interbody spine fusion. Spine (Philadelphia, PA, 1976) 37: E461-467.
147. Song HR, Oh CW, Kyung HS, et al. 2004; Injected calcium sulfate for consolidation of distraction osteogenesis in rabbit tibia. J Pediatr Orthop B 13: 170-175.
148. Stephan SJ, Tholpady SS, Gross B, et al. 2010; Injectable tissue-engineered bone repair of a rat calvarial defect. Laryngoscope 120: 895-901.
149. Struillou X, Boutigny H, Badran Z, et al. 2011; Treatment of periodontal defects in dogs using an injectable composite hydrogel/biphasic calcium phosphate. J Mater Sci Mater Med 22: 1707-1717.
150. Szpalski C, Barr J, Wetterau M, et al. 2010; Cranial bone defects: current and future strategies. Neurosurg Focus 29: E8.
151. Tan RW, Feng QL, Jin H, et al. 2011; Structure and biocompatibility of an injectable bone regeneration composite. J Biomater Sci Polym Ed 22: 1861-1879.
152. Tanag MA, Madura T, Yano K, et al. 2006; Use of calcium phosphate cement paste in orbital volume augmentation. Plast Reconstr Surg 117: 1186-1193.
153. Tanag MA, Yano K, Hosokawa K. 2004; Orbital floor reconstruction using calcium phosphate cement paste: an animal study. Plast Reconstr Surg 114: 1826-1831.
154. Temenoff JS, Mikos AG. 2000; Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 21: 2405-2412.
155. Thorwarth M, Schultze-Mosgau S, Kessler P, et al. 2005; Bone regeneration in osseous defects using a resorbable nanoparticular hydroxyapatite. J Oral Maxillofac Surg 63: 1626-1633.
156. Tian XB, Sun L, Yang SH, et al. 2008; Osteogenic potential of the human bone morphogenetic protein-2 gene activated nanobone putty. Chin Med J 121: 745-751.
157. Torricelli P, Fini M, Giavaresi G, et al. 2002; Characterization of bone defect repair in young and aged rat femur induced by xenogenic demineralized bone matrix. J Periodontol 73: 1003-1009.
158. Truedsson A, Wang JS, Lindberg P, et al. 2010; Bone substitute as an on-lay graft on rat tibia. Clin Oral Implants Res 21: 424-429.
159. Turner TM, Urban RM, Hall DJ, et al. 2003a; Restoration of large bone defects using a hard-setting, injectable putty containing demineralized bone particles compared to cancellous autograft bone. Orthopedics 26: S561-565.
160. Turner TM, Urban RM, Hall DJ, et al. 2003b; Osseous healing using injectable calcium sulfate-based putty for the delivery of demineralized bone matrix and cancellous bone chips. Orthopedics 26: S571-575.
161. Turner TM, Urban RM, Singh K, et al. 2008; Vertebroplasty comparing injectable calcium phosphate cement compared with polymethylmethacrylate in a unique canine vertebral body large defect model. Spine J 8: 482-487.
162. Uda H, Sugawara Y, Nakasu M. 2006; Experimental studies on hydroxyapatite powder-carboxymethyl chitin composite: injectable material for bone augmentation. J Plast Reconstr Aesthet Surg 59: 188-196.
163. Urban RM, Turner TM, Hall DJ, et al. 2004; An injectable calcium sulfate-based bone graft putty using hydroxypropylmethylcellulose as the plasticizer. Orthopedics 27: S155-159.
164. Urban RM, Turner TM, Hall DJ, et al. 2007; Increased bone formation using calcium sulfate-calcium phosphate composite graft. Clin Orthop Rel Res 459: 110-117.
165. Veis A, Kougias K, Tsirlis A, et al. 2009; Evaluation of the osteogenic potential in experimental defects, with and without bone marrow, in the rabbit tibia: a pilot study. Int J Oral Maxillofac Implants 24: 1054-1060.
166. Vertenten G, Vlaminck L, Gorski T, et al. 2008; Evaluation of an injectable, photopolymerizable three-dimensional scaffold based on d, l-lactide and ε{lunate}-caprolactone in a tibial goat model. J Mater Sci Mater Med 19: 2761-2769.
167. Viateau V, Logeart-Avramoglou D, Guillemin G, et al. 2008; Animal models for bone tissue engineering purposes. In Sourcebook of Models for Biochemical Research, Conn PM (ed.). Humana: Totowa, New Jersey.
168. Vlad MD, del Valle LJ, Barraco M, et al. 2008; Iron oxide nanoparticles significantly enhances the injectability of apatitic bone cement for vertebroplasty. Spine 33: 2290-2299.
169. Voor MJ, Arts JJC, Klein SA, et al. 2004; Is hydroxyapatite cement an alternative for allograft bone chips in bone grafting procedures? A mechanical and histological study in a rabbit cancellous bone defect model. J Biomed Mater Res B Appl Biomater 71B: 398-407.
170. Wang X, Ye J, Wang H. 2006; Effects of additives on the rheological properties and injectability of a calcium phosphate bone substitute material. J Biomed Mater Res B Appl Biomater 78: 259-264.
171. Wang ML, Massie J, Allen RT, et al. 2008; Altered bioreactivity and limited osteoconductivity of calcium sulfate-based bone cements in the osteoporotic rat spine. Spine J 8: 340-350.
172. Wang ML, Massie J, Perry A, et al. 2007; A rat osteoporotic spine model for the evaluation of bioresorbable bone cements. Spine J 7: 466-474.
173. Watanabe J, Kashii M, Hirao M, et al. 2007; Quick-forming hydroxyapatite/agarose gel composites induce bone regeneration. J Biomed Mater Res A 83A: 845-852.
174. Weiss P, Obadia L, Magne D, et al. 2003; Synchrotron X-ray microtomography (on a micron scale) provides three-dimensional imaging representation of bone ingrowth in calcium phosphate biomaterials. Biomaterials 24: 4591-4601.
175. Welch RD, Zhang H, Bronson DG. 2003; Experimental tibial plateau fractures augmented with calcium phosphate cement or autologous bone graft. J Bone Joint Surg Am 85A: 222-231.
176. Wood MW, Hart LA. 2011; Selecting appropriate animal models and strains: making the best use of research, information and outreach. In AATEX 14. Proceedings of the 6th World Congress on Alternatives and Animal Use in the Life Sciences; 303-306.
177. Xu W, Ganz G, Weber U, et al. 2011; Evaluation of injectable silica-embedded nanohydroxyapatite bone substitute in a rat tibia defect model. Int J Nanomed 6: 1543-1552.
178. Yamada Y, Ueda M, Naiki T, et al. 2004; Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10: 955-964.
179. Yang XY, Gan YL, Gao X, et al. 2010; Preparation and characterization of trace elements-multidoped injectable biomimetic materials for minimally invasive treatment of osteoporotic bone trauma. J Biomed Mater Res A 95A: 1170-1181.
180. Yao WT, Kong KM, Wang XJ, et al. 2008; Bone regeneration using an injectable calcium phosphate/autologous iliac crest bone composites for segmental ulnar defects in rabbits. J Mater Sci Mater Med 19: 2485-2492.
181. Yoshimi R, Yamada Y, Ito K, et al. 2009; Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering. J Craniofac Surg 20: 1523-1530.
182. Yu XW, Xie XH, Yu ZF, et al. 2009; Augmentation of screw fixation with injectable calcium sulfate bone cement in ovariectomized rats. J Biomed Mater Res B Appl Biomater 89B: 36-44.
183. Yun JI, Wikesjo UME, Borke JL, et al. 2010; Effect of systemic parathyroid hormone (1-34) and a β-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model. J Clin Periodontol 37: 419-426.
184. Zhang WJ, Wang XL, Wang SY, et al. 2011; The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials 32: 9415-9424.
185. Zhu X, Chen X, Chen C, et al. 2011a; Evaluation of calcium phosphate and calcium sulfate as injectable bone cements in sheep vertebrae. J Spinal Disord Tech 25(6): 333-337.
186. Zhu XS, Zhang ZM, Mao HQ, et al. 2011b; A novel sheep vertebral bone defect model for injectable bioactive vertebral augmentation materials. J Mater Sci Mater Med 22: 159-164.